Dr Vijay Ivaturi
Pharmacometrics
Pumas-AI Inc, USA
———————————————————————-
Dr Vijay Ivaturi holds the positions of Co-Founder and CEO at PumasAI, as well as the Endowed Chair and Professor at the Centre for Pharmacometrics at Manipal University, India. Before assuming his current roles, he was a member of the faculty at the University of Maryland Baltimore School of Pharmacy’s Center for Translational Medicine for a decade, subsequently transitioning to an Adjunct Faculty position.
With a steadfast commitment to the advancement of pharmacometrics, Vijay has been an active participant in the pharmacometrics community since the founding of the American Conference on Pharmacometrics (ACoP) in 2008. He has undertaken various responsibilities within the International Society of Pharmacometrics (ISoP) since 2014 and played a pivotal role as the Chair of the Education Committee for several years before being appointed to the ISoP Board in 2020. He is currently the President of ISoP for a 2-year term starting January 2024.
Trained as a clinical pharmacologist and pharmacometrician, Vijay has been instrumental in leading Project Pumas from its inception, passionately developing it into a revolutionary modeling and simulation platform since 2017. His research primarily focuses on the creation of innovative tools and methodologies to enhance drug development and clinical therapeutics.
Vijay completed his doctoral studies in Experimental and Clinical Pharmacology at the University of Minnesota, followed by a post-doctoral fellowship in Pharmacometrics at Uppsala University, Sweden. At the University of Maryland Baltimore, his primary research interest was in developing tools and methods to bridge the gap between decision-makers and scientists, with a special focus on clinical therapeutics in pediatrics. With over 18 years of experience in drug development, he has also contributed to key policy-crafting projects as an ORISE research scholar at the US Food and Drug Administration (FDA).
Note: Click [x] on top-right or anywhere on this pop-up to exit